BioXcel Therapeutics (BTAI) Shares Issued (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Shares Issued of $1037.0 for Q1 2026, down 99.12% year-over-year from $118000.0 in Q1 2025, and down 99.71% quarter-over-quarter from $352000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Shares Issued (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $1037.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 99.12% year-over-year to $1037.0; the TTM figure through Mar 2026 stood at $1037.0 (down 99.12% YoY), while the FY2025 annual figure was $352000.0, up 13.18% from the prior year.
- Shares Issued for Q1 2026 stood at $1037.0, down from $352000.0 in the prior quarter.
- The five-year high for Shares Issued was $4.9 million in Q4 2022, with the low at $560.0 in Q3 2023.
- The 5-year median for Shares Issued is $352000.0 (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2023 and 2024: Shares Issued plunged 99.99% in 2023, then jumped 65792.86% in 2024.
- BioXcel Therapeutics' Shares Issued stood at $4.9 million in 2022, then sank by 93.63% to $311000.0 in 2023, then changed by 0.0% to $311000.0 in 2024, then rose by 13.18% to $352000.0 in 2025, then plunged by 99.71% to $1037.0 in 2026.
- Business Quant data shows BTAI's Shares Issued at $1037.0 in Q1 2026, $352000.0 in Q4 2025, and $106000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.30 Mn | 24.30 Mn | 160,000.00 | 467,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 467,000.00 |
| Jun 30, 2026 | 467,000.00 |
| Mar 31, 2026 | 1,037.00 |
| Mar 31, 2026 | 1,037.00 |
| Dec 31, 2025 | 352,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 106,000.00 |
| Sep 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 1,001.00 |
| Jun 30, 2025 | 1,001.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 311,000.00 |
| Dec 31, 2024 | 311,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 4.83 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 784.00 |
| Mar 31, 2024 | 784.00 |